YTHDF2 and prostate carcinoma: YTHDF2 promotes the progression of gastric cancer,23 oral squamous cell carcinoma,24 hepatocellular carcinoma,25 prostate cancer,26 breast cancer27 and glioblastoma,28 but suppresses the development of colorectal cancer,29 osteosarcoma30 and melanoma.31